Such enzymes include proteolytic enzymes like plasmin, the enzyme responsible for fibrinolysis. Eventually, blood clots are reorganised and resorbed by a process termed "fibrinolysis". This process has two types&colon; primary fibrinolysis and secondary fibrinolysis. Plasmin is an important enzyme that participates in fibrinolysis and degradation of various other proteins. It functions as an inhibitor of fibrinolysis by inhibiting plasmin and kallikrein. Excessive fibrinolysis also causes continuous bleeding. However, acquired disturbance of fibrinolysis (Hyperfibrinolysis), is not uncommon. X. Another contributing factor may be enhanced fibrinolysis, the breakdown of clots. As a result, both the intrinsic pathway of coagulation and fibrinolysis are inhibited. Impaired liver synthesis of clotting factors, low-grade fibrinolysis, and intravascular coagulation are typical of ALF. The detection of these dimers in blood is used as a clinical test for fibrinolysis. Testing of overall fibrinolysis can be measured by a euglobulin lysis time (ELT) assay. This is more specific than the TCT, and confirms that fibrinolysis has occurred. The degradation of fibrin is termed fibrinolysis. Factors which promote fibrinolysis include local trauma, estrogens, and pyrogens from bacteria.